1st BEACH course

Register for IFAD

1th BEACH COURSE: BElgian Annual eCmo Hands-on course (Limited places during IFAD2017)

Date: November 23rd, 2017

Location: Hilton Congress Centre, Groenplaats, Antwerp, Belgium

Room: TBA

Chairs and Speakers:

• Prof Dr Filip De Somer, University Hospital, Ghent, Belgium
• Dr Dirk Donker, UMC, Utrecht, The Netherlands
• Dr Rita Jacobs, University Hospital (UZB), Brussels, Belgium
• Prof Dr  Fabio Taccone, ULB Erasme Hospital, Brussels, Belgium
• Mevr. Miranda Van Bommel, Sophia Kinderziekenhuis, ErasmusMC, Rotterdam, The Netherlands

Hands-on Instructors:

All Faculty +

• Linda Van den Avont, Getinge Accountmanager ACT BeLux, Erpe Mere, Belgium
• Tim Teunissen, Getinge Account Manager, Clinical Application Specialist, Assist Devices, Acute Care Therapies BeNeLux, Hilversum, The Netherlands
• Chris Stortenbeker, Xenios clinical support specialist, Heilbronn, Germany
• Kim van der Maat, Xenios clinical support specialist, Heilbronn, Germany

Duration: Full Day 9:00 – 18:00

Pax: limited to a max of 40

Price: exceptionally low @ 200 EUR (meals and drinks included)

Comment: This workshop can be booked either separately or in combination with attending the IFAD2017 meeting on Nov 24-25, 2017, at Hilton Congress Centre, Groenplaats, Antwerp, Belgium

Learning objective: This workshop will outline the basic principles of extracorporeal life support made easy by key-experts in the field. During the course delegates will gain a good understanding of ECMO in the following areas: Theoretical concepts, basic physiology and pathophysiology, cardiac and respiratory support and monitoring, alarm settings and monitoring, role of cardiac ultrasound during ECMO, newest technologies, circuits and devices, practical hands-on sessions and simulations.

Background: The BEACH programme provides a full-day, interactive course on Extracorporeal Membrane Oxygenation (ECMO) training. The course uses a variation of theoretical presentations, practical and simulation sessions presented by an international faculty. It is the only course in Belgium to be endorsed by the International Fluid Academy and has also been accredited by the EACCME for 9 points. The course is inclusive of all course materials, food and drinks at the Hilton Congress and Conference Centre, Groenplaats in Antwerp, Belgium. Delegates will have opportunity to meet, greet and ask questions regarding all topics presented.

Hands-on ECMO equipment training
Delegates will have the opportunity to have hands-on training in small break-out groups with ECMO equipment. Delegates will experience practicing insertion of cannulas on a mannekin, circuit surveillance, monitoring, alarm settings, simulations and trouble-shooting.

Programme:

The course was made available via Unrestricted Educational Grants from Getinge and Xenios

Getinge AB is a Sweden-based company active in the healthcare sector. It provides products and services for intensive care units, sterilization centers, elderly care and companies and institutions active in the life sciences area. Its operations are divided into three business areas: The Medical Systems business area offers equipment for surgical disciplines, cardiology and intensive care; the Extended Care business area offers products and services geared toward the hospital and elderly care markets, including solutions for preventing the risk of pressure ulcers and deep vein thrombosis, and the Infection Control business area features systems for preventing the occurrence and spread of infection. Its products comprise disinfectors, sterilizers, including low temperature sterilization solutions, information technology (IT) solutions, as well as advice, training and technical support. The Company's products are sold under the Getinge, Lancer, ArjoHuntleigh and MAQUET brands. Product information: https://www.maquet.com/int/workspaces/operating-room/?filter=24

XENIOS is the therapy and technology leader in minimally invasive lung and heart assist. XENIOS’ novalung iLA, i–cor, and medos devices provide pulmonary and cardiac assist for a broad range of support levels on the unique XENIOS platform. XENIOS’ novalung iLA therapy is an adjunct or an alternative to injurious, immobilizing mechanical ventilation. XENIOS i-cor therapy is a novel less invasive heart assist therapy synchronized with the human heartbeat. These therapies enable caregivers to keep lung failure patients awake, self-determined and mobile while preventing ventilator-associated lung injury, pneumonia, and breathing muscle damage. Xenios is now integrated within Fresenius Medical Care. Product information: http://www.xenios-campus.com

Suggested reading and websites:

1. ECLS guidelines for adult respiratory failure: https://www.elso.org/Portals/0/IGD/Archive/FileManager/989d4d4d14cusersshyerdocumentselsoguidelinesforadultrespiratoryfailure1.3.pdf
2. ELSO guidelines for ECMO centres: https://www.elso.org/portals/0/igd/archive/filemanager/faf3f6a3c7cusersshyerdocumentselsoguidelinesecmocentersv1.8.pdf
3. Alfred Health ECMO guidelines: http://www.alfredicu.org.au/assets/Documents/ICU-Guidelines/ECMO/ECMOGuideline.pdf
4. Extracorporeal membrane oxygenation for severe acute respiratory failure in adults (NICE guideline): https://www.nice.org.uk/guidance/ipg391
5. Extracorporeal membrane oxygenation (ECMO) for acute heart failure in adults (NICE guideline): https://www.nice.org.uk/guidance/ipg482
6. European Society of Cardiology
7. National Specialised Commissioning Team on ECMO
8. ExtraCorporeal Life Support Organisation

picture courtesy http://wlpapers.com/sea-palm-beach.html#gal_post_8323_sea-palm-beach-1.jpg

Register for IFAD